amiodarone has been researched along with Muscle Weakness in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| " She was recently diagnosed with refractory atrial flutter and was prescribed amiodarone." | 3.79 | Ataxia: a diagnostic perplexity and management dilemma. ( Chaubey, VK; Chhabra, L; Kapila, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzanti, A | 1 |
| Guz, D | 1 |
| Trancuccio, A | 1 |
| Pagan, E | 1 |
| Kukavica, D | 1 |
| Chargeishvili, T | 1 |
| Olivetti, N | 1 |
| Biernacka, EK | 1 |
| Sacilotto, L | 1 |
| Sarquella-Brugada, G | 1 |
| Campuzano, O | 1 |
| Nof, E | 1 |
| Anastasakis, A | 1 |
| Sansone, VA | 1 |
| Jimenez-Jaimez, J | 1 |
| Cruz, F | 1 |
| Sánchez-Quiñones, J | 1 |
| Hernandez-Afonso, J | 1 |
| Fuentes, ME | 1 |
| Średniawa, B | 1 |
| Garoufi, A | 1 |
| Andršová, I | 1 |
| Izquierdo, M | 1 |
| Marinov, R | 1 |
| Danon, A | 1 |
| Expósito-García, V | 1 |
| Garcia-Fernandez, A | 1 |
| Muñoz-Esparza, C | 1 |
| Ortíz, M | 1 |
| Zienciuk-Krajka, A | 1 |
| Tavazzani, E | 1 |
| Monteforte, N | 1 |
| Bloise, R | 1 |
| Marino, M | 1 |
| Memmi, M | 1 |
| Napolitano, C | 1 |
| Zorio, E | 1 |
| Monserrat, L | 1 |
| Bagnardi, V | 1 |
| Priori, SG | 1 |
| Chaubey, VK | 1 |
| Chhabra, L | 1 |
| Kapila, A | 1 |
| Mahitchi, E | 1 |
| Balagué, F | 1 |
| Waldburger, M | 1 |
| Verswijvel, G | 1 |
| Franssens, Y | 1 |
| Deraemaeker, L | 1 |
| Leyssens, G | 1 |
| Govaerts, E | 1 |
| Theunissen, P | 1 |
4 other studies available for amiodarone and Muscle Weakness
| Article | Year |
|---|---|
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Andersen Syndrome; Anti-Arrhythmia Agent | 2020 |
Ataxia: a diagnostic perplexity and management dilemma.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Ataxia; Atrial Flutter; Diagnosis, Differential; Female; F | 2013 |
[What is your diagnosis. Myopathy due to hypothyroidism aggravated by amiodarone].
Topics: Accidental Falls; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagno | 2009 |
Amiodarone induced pulmonary toxicity.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; Amiodarone; Anti-Arrhythmia Agents; Aspartate Aminotr | 1998 |